Literature DB >> 22711506

Enhanced S-cone syndrome with preserved macular structure and severely depressed retinal function.

Ivan Cima1, Jelka Brecelj, Maja Sustar, Frauke Coppieters, Bart P Leroy, Elfride De Baere, Marko Hawlina.   

Abstract

We present ophthalmic features and genetic analysis findings of a 44-year-old croatian patient with enhanced S-cone syndrome (ESCS). Complete ophthalmic examination, Ishihara colour vision test, dark adaptometry, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence imaging, Goldmann visual field and automated perimetry, full-field electroretinography (ERG), multifocal ERG, S-cone ERG and ON-OFF ERG were performed. Mutation screening of the NR2E3 gene, which encodes a photoreceptor-specific orphan nuclear receptor, was performed with polymerase chain reaction amplification and direct sequencing. The patient has good visual acuity and normal colour vision. Fundus examination showed normal posterior pole and nummular pigment depositions at the level of the retinal pigment epithelium in the mid-periphery of the retina. The SD-OCT images showed normal macular structure and thickness. The ERG showed characteristic findings: photopic and scotopic responses to the same stimulus had a similar waveform and were dominated by short-wavelength-sensitive mechanisms. Mutation analysis revealed the known NR2E3 mutation c.481delA (p.Thr161HisFsX18) and the novel NR2E3 variant c.1120C > T (p.Leu374Phe). To the best of our knowledge, this is the only ESCS patient older than 40 years who phenotypically has preserved macular structure, good central visual acuity and severely depressed full-field ERG as well as the first reported patient with NR2E3 mutation from Croatia.

Entities:  

Mesh:

Year:  2012        PMID: 22711506     DOI: 10.1007/s10633-012-9337-y

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  26 in total

1.  Identification of a photoreceptor cell-specific nuclear receptor.

Authors:  M Kobayashi; S Takezawa; K Hara; R T Yu; Y Umesono; K Agata; M Taniwaki; K Yasuda; K Umesono
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  A novel mutation (Cys83Tyr) in the second zinc finger of NR2E3 in enhanced S-cone syndrome.

Authors:  Amândio Rocha-Sousa; Takaaki Hayashi; Nuno Lourenço Gomes; Susana Penas; Elisete Brandão; Paulo Rocha; Mitsuyoshi Urashima; Hisashi Yamada; Hiroshi Tsuneoka; Fernando Falcão-Reis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-20       Impact factor: 3.117

3.  Macular function assessed by microperimetry in patients with enhanced S-cone syndrome.

Authors:  Elliott H Sohn; Fred K Chen; Gary S Rubin; Anthony T Moore; Andrew R Webster; Robert E MacLaren
Journal:  Ophthalmology       Date:  2010-02-19       Impact factor: 12.079

4.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

5.  The enhanced S cone syndrome: an analysis of receptoral and post-receptoral changes.

Authors:  V C Greenstein; Q Zaidi; D C Hood; B Spehar; A V Cideciyan; S G Jacobson
Journal:  Vision Res       Date:  1996-11       Impact factor: 1.886

6.  Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity.

Authors:  Takaaki Hayashi; Tamaki Gekka; Satoshi Goto-Omoto; Tomokazu Takeuchi; Akiko Kubo; Kenji Kitahara
Journal:  Ophthalmology       Date:  2005-10-12       Impact factor: 12.079

7.  The spectrum of retinal diseases caused by NR2E3 mutations in Israeli and Palestinian patients.

Authors:  Dikla Bandah; Saul Merin; Munther Ashhab; Eyal Banin; Dror Sharon
Journal:  Arch Ophthalmol       Date:  2009-03

8.  Shared mutations in NR2E3 in enhanced S-cone syndrome, Goldmann-Favre syndrome, and many cases of clumped pigmentary retinal degeneration.

Authors:  Dror Sharon; Michael A Sandberg; Rafael C Caruso; Eliot L Berson; Thaddeus P Dryja
Journal:  Arch Ophthalmol       Date:  2003-09

9.  Phenotypic variation in enhanced S-cone syndrome.

Authors:  Isabelle Audo; Michel Michaelides; Anthony G Robson; Marko Hawlina; Veronika Vaclavik; Jennifer M Sandbach; Magella M Neveu; Chris R Hogg; David M Hunt; Anthony T Moore; Alan C Bird; Andrew R Webster; Graham E Holder
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

10.  Diagnostic clinical findings of a new syndrome with night blindness, maculopathy, and enhanced S cone sensitivity.

Authors:  M F Marmor; S G Jacobson; M H Foerster; U Kellner; R G Weleber
Journal:  Am J Ophthalmol       Date:  1990-08-15       Impact factor: 5.258

View more
  5 in total

1.  Electroretinography and optical coherence tomography reveal abnormal post-photoreceptoral activity and altered retinal lamination in patients with enhanced S-cone syndrome.

Authors:  M Sustar; D Perovšek; I Cima; B Stirn-Kranjc; M Hawlina; J Brecelj
Journal:  Doc Ophthalmol       Date:  2015-02-07       Impact factor: 2.379

2.  ISCEV extended protocol for the S-cone ERG.

Authors:  Ido Perlman; Mineo Kondo; Enid Chelva; Anthony G Robson; Graham E Holder
Journal:  Doc Ophthalmol       Date:  2019-11-20       Impact factor: 2.379

3.  New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome.

Authors:  Kazuki Kuniyoshi; Takaaki Hayashi; Hiroyuki Sakuramoto; Hiroshi Mishima; Hiroshi Tsuneoka; Kazushige Tsunoda; Takeshi Iwata; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2016-08-13       Impact factor: 2.447

4.  Peripheral Cone Dystrophy: Expanded Clinical Spectrum, Multimodal and Ultrawide-Field Imaging, and Genomic Analysis.

Authors:  Robert A Sisk; Robert B Hufnagel; Ailee Laham; Elizabeth S Wohler; Nara Sobreira; Zubair M Ahmed
Journal:  J Ophthalmol       Date:  2018-07-11       Impact factor: 1.909

5.  Novel Pathogenic Sequence Variants in NR2E3 and Clinical Findings in Three Patients.

Authors:  Saoud Al-Khuzaei; Suzanne Broadgate; Stephanie Halford; Jasleen K Jolly; Morag Shanks; Penny Clouston; Susan M Downes
Journal:  Genes (Basel)       Date:  2020-10-29       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.